December 19, 2007 (New York, NY) – A new beta blocker, nebivolol (Bystolic, Forest/Mylan), has been approved by the US FDA for the treatment of hypertension. The drug is a selective beta 1 blocker and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results